Meteorologia

  • 14 NOVEMBER 2024
Tempo
MIN 8º MÁX 17º

Parkinson's: Antibody may delay symptoms, study says

The conclusion is from a clinical trial conducted at the Roche Innovation Centre in Switzerland. The research was published in the journal Nature Medicine.

Parkinson's: Antibody may delay symptoms, study says
Notícias ao Minuto

07:50 - 17/04/24 por Notícias ao Minuto

Lifestyle Parkinson

A research carried out at the Roche Innovation Center, in Switzerland, has found a monoclonal antibody that is able to reduce the symptoms of Parkinson's in patients with a rapid progression of the disease.

According to the journal Nature Medicine, the experimental therapeutic antibody is called prasinezumab and is able to bind to the alpha-synuclein protein, a key factor in the progression of the disease.

Read Also: Experts Say We Should 'Feed' the Brain with These Spices (Portuguese version)

Its effectiveness can be seen after just one year. The phase two trial, called Pasadena, analyzed the effect of this antibody on 316 patients. The treatment reduced the symptoms of rapid progression after 52 weeks.

Despite the results, investors reveal that more research is needed to confirm these effects.

"The improvement obtained is very limited with a time of only one year. It is really difficult to predict the results of this type of treatment in the long term", revealed to the HuffPost blog aggregator José Luis Lanciego, a researcher at the University of Navarra, in Spain, who did not participate in the study.

Read Also: Parkinson's. "Exercise can improve symptoms and delay its progression" (Portuguese version)

Recomendados para si

;

Receba dicas para uma vida melhor!

Moda e Beleza, Férias, Viagens, Hotéis e Restaurantes, Emprego, Espiritualidade, Relações e Sexo, Saúde e Perda de Peso

Obrigado por ter ativado as notificações de Lifestyle ao Minuto.

É um serviço gratuito, que pode sempre desativar.

Notícias ao Minuto Saber mais sobre notificações do browser

Campo obrigatório